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Shigella flexneri serotype 2 variant (II:3,4,7,8) was isolated in 2008 and first reported in
China in 2013. In the present study, epidemiological surveillance from 2003 to 2013 in
China suggested that this serotype first appeared in Guangxi in 2003; it then emerged
in Shanghai and Xinjiang in 2004 and in Henan in 2008. Of the 1813 S. flexneri isolates,
58 S. flexneri serotype 2 variant strains were identified. Serotype 2 variant has emerged
as a prominent serotype in recent years, with 2a (32.6%), X variant (25.2%), 1a (9.4%),
X (6.3%), 2b (5.4%), and 1b (3.6%). According to phenotypic and genotypic analysis,
the serotype 2 variant originated from 2a to 2b. A higher antibiotic resistance rate
was observed between 2009 and 2013 than that between 2003 and 2008. Among 22
cephalosporin-resistant isolates, blaTEM−1, blaOXA−1, blaCTX−3, blaCTX−14, and blaCTX−79
were detected. Among 22 fluoroquinolone-resistant isolates, a Ser80Ile mutation in parC
was present in all of the isolates. Moreover, 21 isolates had three gyrA point mutations
(Ser83Leu, His211Tyr, Asp87Asn, or Gly) and one isolate had two gyrA point mutations
(Ser83Leu and His211Tyr). The prevalence of His211Tyr in the fluoroquinolone-resistant
isolates is concerning, and the mutation was first reported in China. Besides, 22
isolates harbored the aac(6′)-Ib-cr gene, and two isolates harbored qnrS1. In view of
the increased epidemic frequency and multidrug-resistant strain emergence, continuous
surveillance will be needed to understand the actual disease burden and provide
guidance for shigellosis.
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Introduction
Shigellosis, caused by Shigella species, is recognized as a major public health burden and continues
to be an important cause of diarrheal diseases. Worldwide, Shigella episodes were estimated to
be 164.7 million annually, of which, 163.2 million were in developing countries, resulting in 1.1
million deaths (Kotloff et al., 1999). Epidemics generally occur in underdeveloped and developing
countries with poor sanitary conditions where transmission from person to person is common,
or when food or water is contaminated by the organism (Qu et al., 2012). Despite economic and
public health improvements, outbreaks of shigellosis are still reported regularly (Huang et al., 2005;
Gaynor et al., 2009; Kuo et al., 2009; Qiu et al., 2011). In China, shigellosis has been ranked third in
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morbidity, and it has become the number one cause of
disease-related death in children (Mathers et al., 2009).
Based on biochemical and serological properties, the genus
Shigella is divided into four species or subgroups: S. flexneri, S.
dysenteriae, S. boydii, and S. sonnei. Among these subgroups, the
epidemic subgroup S. sonnei caused diarrhea in industrialized
countries and S. flexneri in developing countries (Kotloff et al.,
1999). A previous study showed that the annual shigellosis
morbidity rate was 20.28 cases per 100,000 people in mainland
China from the national surveillance data of 2009, and S. flexneri
(67.3%) and S. sonnei (32.7%) were two major causative species
(Sui et al., 2010). S. flexneri is divided into at least 20 serotypes
(serotypes 1a, 1b, 1c, 1d, 2a, 2b, 2 variant, 3a, 3b, 4a, 4av, 4b, 5a, 5b,
X, Xv, Y, Yv, F6, and 7b) based on the combinations of antigenic
determinants present on the O antigen of the cell envelope
lipopolysaccharide (Qiu et al., 2013; Sun et al., 2013). Serotypes
1c, 4av, 7b, 1d, Yv, 2 variant and Xv are newly reported serotypes
in recent years, and some have caused epidemic-level disease
(Talukder et al., 2001; Stagg et al., 2008; Ye et al., 2010). Serotype
1c, first appeared in Bangladesh in 1989, was subsequently found
to be prevalent in Bangladesh, Egypt, and Vietnam (Carlin et al.,
1989; El-Gendy et al., 1999; Stagg et al., 2008). Serotype Xv
was first identified in 2000 and later become the predominant
serotype in Henan Province between 2002 and 2006. Serotype
Xv was also the most prevalent serotype in Gansu and Anhui in
2007 (Ye et al., 2010). Therefore, the rapid expansion and spread
of novel serotypes pose a severe threat to public health in areas
where shigellosis is endemic.
The S. flexneri serotype 2 variant (II:3,4,7,8) was first reported
by Qiu et al. in 2013 (Qiu et al., 2013). During our routine
surveillance of bacillary dysentery from 2003 to 2013, a total of
58 serotype 2 variant strains were identified. This novel serotype
first appeared in Guangxi in 2003, and then emerged in other
provinces. However, no study has yet extensively characterized
the newly emerging strains of serotype 2 variant; therefore,
an extensive study is needed to determine the emergence,
antimicrobial resistance pattern, and epidemic trends of the
serotype 2 variant.
Materials and Methods
Bacterial Isolates, Serotyping, and Biochemical
Characterization
Fresh stool samples from diarrhea patients with clinically
suspected dysentery were collected in sentinel hospitals. Samples
were cultured for Shigella by streaking directly onto Salmonella–
Shigella agar and incubated at 37◦C for 18 h. Resultant Shigella
colonies (colorless, semitransparent, smooth, and moist circular
colonies) were routinely grown in a 37◦C incubator in Luria–
Bertani agar plates (Qu et al., 2012). Then, the strains were
submitted to our laboratory for further confirmation. This study
was approved by the ethics committee of the Academy ofMilitary
Medical Sciences (China), andwritten approval was also obtained
from the patients involved in this study. The isolates were
confirmed using API 20E test strips (bioMerieux Vitek, Marcy-
l’Etoile, France) following the manufacturer’s recommendations.
Serotypes of Shigella isolates were further determined with two
serotyping kits: a commercially available kit (Denka Seiken,
Tokyo, Japan) and monoclonal antibody reagents (Reagensia AB,
Stockholm, Sweden).
Multilocus Sequence Typing (MLST)
MLST of these isolates was carried out using the protocols
described at http://www.shigatox.net/ecmlst/cgi-bin/index. The
PCR amplification conditions were as follows: 94◦C for 5min;
33 cycles of 94◦C for 30 s, 55◦C for 30 s, and 72◦C for 1min;
and 72◦C for 10min with Ex Taq DNA polymerase (Takara,
Dalian, China). The PCR amplicons of 15 housekeeping genes
were sequenced, and sequences were edited using SeqMan 7.0.
Then, the sequences were uploaded to the EcMLST website for
comparison, which allowed us to determine the sequence type.
Antimicrobial Susceptibility Testing
The antimicrobial MICs of 21 antimicrobials including
ceftazidime (CAZ), ceftriaxone (CRO), cefepime (FEP),
cefoperazone (CFP), cefazolin (CFZ), cefoxitin (FOX),
imipenem (IPM), nitrofurantoin (NIT), piperacillin (PIP),
ampicillin (AMP), ticarcillin (TIC), tetracycline (TE),
tobramycin (TO), gentamicin (GEN), amikacin (AK),
aztreonam (ATM), chloramphenicol (C), ticarcillin/clavulanic
acid (TIM), levofloxacin (LEV), norfloxacin (NOR), and
trimethoprim/sulfamethoxazole (SXT) were determined
by broth microdilution using a 96-well microtiter plate
(Sensititre, Thermo Fisher Scientific Inc., West Sussex, United
Kingdom) according to the manufacturer’s instructions, and
MIC values follow Clinical and Laboratory Standards Institute
recommendations. An Escherichia coli (ATCC 25922) strain was
used as the quality control strain.
Pulsed-Field Gel Electrophoresis (PFGE)
All isolates of S. flexneri were analyzed by PFGE according to
the standard protocol for S. flexneri developed by the Centers
for Disease Control and Prevention of the USA. Salmonella
enterica serotype Braenderup H9812 was digested with XbaI
and used as molecular weight standard. Slices of agarose plugs
were digested with NotI (Takara, Dalian, China) at 37◦C for
3 h. Electrophoresis was carried out in 1% agarose SeaKem
Gold gel (Lonza, Rockland, ME, USE) with the CHEF Mapper
system (Bio-Rad) with the following run parameters: 6 V/cm
and a linear increase in switching times from 2.16 to 54.17 s
over a period of 20 h. The interpretation of the PFGE patterns
was performed with BioNumerics software version 6.0 (Applied
Maths, Sint-Martens-Latem, Belgium). A tree indicating relative
genetic similarity was constructed based on the unweighted pair
group method of averages and a position tolerance of 1.2%.
PCR Amplification of the Antibiotic-Resistant
Determinants and Integrons
To understand the underlying mechanism conferring resistance
to third-generation cephalosporins, PCR assays (Ahmed et al.,
2006; Pan et al., 2006; Matar et al., 2007; Galani et al., 2010; Tariq
et al., 2012) were used to detect the presence of β-lactamase genes
such as blaSHV, blaTEM, blaOXA, and blaCTX−M. The variable
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TABLE 1 | Primers for the antibiotic-resistant determinants and integrons.
Target Primer sequence (5′–3′) Amplicon size (bp) References
β-Lactamases
blaCTX-M-1 group F: GGTTAAAAAATCACTGCGTC
R: TTACAAACCGTCGGTGACGA
873 Matar et al., 2007
blaCTX-M-9 group F: AGAGTGCAACGGATGATG
R: CCAGTTACAGCCCTTCGG
868 Matar et al., 2007
blaCTX-M-2/8/25 group F: ACCGAGCCSACGCTCAA
R: CCGCTGCCGGTTTTATC
221 This study
blaTEM F: ATGAGTATTCAACATTTCCG
R: CCAATGCTTAATCAGTGAGG
1080 Tariq et al., 2012
blaOXA F: ATTAAGCCCTTTACCAAACCA
R: AAGGGTTGGGCGATTTTGCCA
890 Ahmed et al., 2006
blaVIM F: AGTGGTGAGTATCCGACAG
R: ATGAAAGTGCGTGGAGAC
509 Galani et al., 2010
blaNDM F: GTCTGGCAGCACACTTCCTA
R: TAGTGCTCAGTGTCGGCATC
515 This study
INTEGRONS
IntI1 F: ACATGTGATGGCGACGCACGA
R: ATTTCTGTCCTGGCTGGCGA
569 Pan et al., 2006
Class 1 integron variable region hep58: TCATGGCTTGTTATGACTGT
hep59:GTAGGGCTTATTATGCACGC
Variable This study
Class 1 integron variable region hep58: TCATGGCTTGTTATGACTGT
aadA1:TGTCAGCAAGATAGCCAGAT
Variable This study
Class 1 integron variable region hep58: TCATGGCTTGTTATGACTGT
aadA2: TGATCTCGCCTTTCACAAA
Variable This study
Class 1 integron variable region hep58: TCATGGCTTGTTATGACTGT
aadA5: CATCTAACGCATAGTTGAGC
Variable This study
Class 1 integron variable region hep58: TCATGGCTTGTTATGACTGT
cmlA1: CAACGATTGGGATTTGACGTACTTT
Variable This study
IntI2 F: CACGGATATGCGACAAAAAGGT
R: GTAGCAAACGAGTGACGAAATG
789 Pan et al., 2006
Class 2 integron variable region hep74: CGGGATCCCGGACGGCATGCACGATTTGTA
hep51: GATGCCATCGCAAGTACGAG
Variable Ahmed et al., 2006
QRDR OF TOPISOMERASE GENES
gyrA F: TACACCGGTCAACATTGAGG
R: TTAATGATTGCCGCCGTCGG
648 Hu et al., 2007
gyrB F: TGAAATGACCCGCCGTAAAGG
R: GCTGTGATAACGCAGTTTGTCCGGG
309 Hu et al., 2007
parC F: GTACGTGATCATGGACCGTG
R: TTCGGCTGGTCGATTAATGC
531 Hu et al., 2007
parE F: ATGCGTGCGGCTAAAAAAGTG
R: TCGTCGCTGTCAGGATCGATAC
290 Hu et al., 2007
PMQR
qnrA F: ATTTCTCACGCCAGGATTTG
R: GATCGGCAAAGGTYAGGTCA
516 Robicsek et al., 2006
qnrB F: GATCGTGAAAGCCAGAAAGG
R: ACGAYGCCTGGTAGTTGTCC
469 Robicsek et al., 2006
qnrD F: CGAGATCAATTTACGGGGAATA
R: AACAAGCTGAAGCGCCTG
656 Tariq et al., 2012
qnrS F: ACGACATTCGTCAACTGCAA
R: TAAATTGGCACCCTGTAGGC
417 Robicsek et al., 2006
aac(6′)-Ib-cr F: GCAACGCAAAAACAAAGTTAGG
R: GTGTTTGAACCATGTACA
560 Pu et al., 2009
regions of class 1 integrons and class 2 integrons were also
amplified with primers listed in Table 1. The primers hep58
and hep59, hep74 and hep51 were used to detect the variable
regions of class 1 integrons and class 2 integrons, respectively.
The reverse primers aadA1, aadA2, aadA5, and cmlA1, together
with the forward primer hep58, were used to amplify the gene
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cassettes of class 1 integron-positive strains. The forward primer
hep74 and reverse primer hep51 were used to amplify the gene
cassettes of class 2 integron-positive strains. To understand
the underlying mechanism conferring resistance to quinolones,
plasmid-mediated quinolone resistance determinants (PMQRs)
such as qnrA, qnrB, qnrD, qnrS, and aac(6′)-Ib-cr and quinolone
resistance–determining regions (QRDRs) of the DNA gyrase
(gyrA) and topoisomerase IV (parC) genes were amplified
(Robicsek et al., 2006; Hu et al., 2007; Pu et al., 2009; Tariq et al.,
2012). Purified PCR fragments were sequenced and analyzed by
comparison with sequences in GenBank.
Results
Bacteria Isolation and Biochemical
Characterization
During the routine surveillance of shigellosis in our laboratory,
we screened 1813 S. flexneri isolates collected from the eastern,
FIGURE 1 | Shigella flexneri species distribution from 2003 to 2013 in China.
FIGURE 2 | S. flexneri species proportions from 2003 to 2013 in China.
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TABLE 2 | Comparison and antimicrobial susceptibility to 21 antibiotics among S. flexneri serotype 2 variant isolates from different regions.
Antibiotic Antimicrobial resistance rate No. (%)
Total (n = 58) Shanghai (n = 34) Henan (n = 12) Xinjiang (n = 8) Guangxi (n = 4)
Ceftazidime 0 0 0 0 0
Ceftriaxone 20 (34.5%) 12 (35.3%) 4 (33.3%) 4 (50%) 0
Piperacillin 14 (24.1%) 10 (29.4%) 2 (16.7%) 2 (25%) 0
Tetracycline 55 (94.8%) 31 (91.2%) 12 (100%) 8 (100%) 4 (100%)
Cefoperazone 17 (29.3%) 9 (26.5%) 4 (33.3%) 4 (50%) 0
Cefazolin 22 (37.9%) 14 (41.2%) 4 (33.3%) 4 (50%) 0
Ticarcillin 56 (96.6%) 33 (97.1%) 12 (100%) 7 (87.5%) 4 (100%)
Ticarcillin/clavulanic acid 3 (5.2%) 2 (5.9%) 0 1 (3.6%) 0
Aztreonam 2 (3.4%) 0 1 (8.3%) 1 (3.6%) 0
Ampicillin 57 (98.3%) 33 (97.1%) 12 (100%) 8 (100%) 4 (100%)
Chloramphenicol 54 (93.1%) 31 (91.2%) 12 (100%) 7 (87.5%) 4 (100%)
Trimethoprim/sulfamethoxazole 25 (43.1%) 16 (47.1%) 4 (33.3%) 3 (37.5%) 2 (50%)
Levofloxacin 1 (1.7%) 0 0 1 (12.5%) 0
Cefepime 0 0 0 0 0
Imipenem 0 0 0 0 0
nitrofurantoin 2 (3.4%) 2 (5.9%) 0 0 0
Cefoxitin 3 (5.2%) 3 (8.8%) 0 0 0
Tobramycin 7 (12.1%) 5 (14.7%) 2 (16.7%) 0 0
Gentamicin 5 (8.6%) 4 (11.2%) 1 (8.3%) 0 0
Norfloxacin 22 (37.9%) 16 (47.1%) 3 (25%) 3 (37.5%) 0
Amikacin 0 0 0 0 0
western, southern, northern and central regions of China during
2003–2013. In the 11-year surveillance of Shigella infections, a
total of 58 S. flexneri serotype 2 variant isolates were identified.
The serotype 2 variant first appeared in Guangxi Province in
2003, then emerged in Shanghai City and Xinjiang Province in
2004, and it was found in Henan Province in 2008. Among the
58 serotype 2 variant isolates, 34 isolates were collected from
Shanghai City during the period 2005–2013, 12 isolates were
collected from Henan Province during the period 2008–2010,
eight isolates were collected from Xinjiang Province during the
period 2004–2012, and four isolates were collected from Guangxi
Province during the period 2003–2007 (Figure 1; see also Table
S1 in the Supplemental Material). Notably, serotype 2 variant has
emerged as a common serotype (3.2%), with 2a (32.6%), X variant
(25.2%), 1a (9.4%), X (6.3%), 2b (5.4%) and 1b (3.6%) during
2003–2013 (Figure 2). In addition, all examined strains of S.
flexneri serotype 2 variant displayed the same typical biochemical
features of Shigella species with the ability to ferment glucose,
arabinose, mannitol, and melibiose.
Antimicrobial Susceptibility Testing
Fifty-eight S. flexneri serotype 2 variant isolates were tested
for MICs with 21 antimicrobials. Resistance to ampicillin
was the most common (57, 98.3%), followed by ticarcillin
(56, 96.6%), tetracycline (55, 94.8%), chloramphenicol (54,
93.1%), trimethoprim/sulfamethoxazole (25, 43.1%), norfloxacin
(22, 37.9%), cefazolin (22, 37.9%), ceftriaxone (20, 34.5%),
cefoperazone (17, 29.3%), piperacillin (14, 24.1%), tobramycin
(7, 12.1%), gentamicin (5, 8.6%), ticarcillin/clavulanic acid (3,
5.2%), cefoxitin (3, 5.2%), nitrofurantoin (2, 3.4%), aztreonam
(2, 3.4%), and levofloxacin (1, 1.7%). None of the isolates
were resistant to cefepime, imipenem, ceftazidime, and
amikacin. In addition, strains intermediately resistant to
ceftazidime, cefoperazone, levofloxacin, norfloxacin, piperacillin,
tobramycin, gentamicin, aztreonam, and ticarcillin/clavulanic
acid were also observed (Table 2). Furthermore, 57 of 58 S.
flexneri serotype 2 variant isolates exhibited multidrug-resistant
(MDR; resistant to three or more classes of antimicrobials),
and only one strain from Shanghai was not. All of the
isolates had 26 antibiotic-resistance profiles, dominated by
resistance to TE/TIC/AMP/C (14/58, 24.1%), followed by
TE/TIC/AMP/C/SXT (8/58, 13.8%), TE/TIC/AMP/C/SXT/NOR
(5/58, 8.6%), and TE/TIC/AMP/C/NOR (3/58, 5.2%) (Table 3).
Moreover, notable differences of antibiotic resistance profiles
were also observed during the periods 2003–2008 and 2009–
2013. Of the 58 serotype 2 variant strains, the resistance rate
to cephalosporin and quinolones was 33.3% and 17.9% during
2003–2008, respectively, which increased to 47.4% and 78.9%
during 2009–2013. The resistance rate to both cephalosporin
and quinolones was 5.1% during 2003–2008, which increased to
42.1% during 2009–2013 (Table 4).
MLST and PFGE Analysis
To determine the phylogenetic relationship of these serotype
2 variant strains, an extended MLST scheme of 15 genes was
performed. We found that all the isolates in this study belonged
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TABLE 3 | Dominant antimicrobial resistance profiles of 58 Shigella flexneri serotype 2 variant isolates from different regions of China.
Antimicrobial resistance profiles Total Xinjiang Shanghai Henan Guangxi
No. (%) (n = 58) No. (%) (n = 8) No. (%) (n = 34) No. (%) (n = 12) No. (%) (n = 4)
TE/SXT 1 (1.7%) 0 1 (2.9%) 0 0
TE/TIC/AMP/C 14 (24.1%) 2 (25%) 6 (17.6%) 4 (33.3%) 2 (50%)
TIC/AMP/C/NOR 2 (3.4%) 0 2 (5.9%) 0 0
TE/TIC/AMP/C/SXT 8 (13.8%) 1 (12.5%) 2 (5.9%) 3 (25%) 2 (50%)
TE/TIC/AMP/C/NOR 3 (5.2%) 1 (12.5%) 2 (5.9%) 0 0
TIC/AMP/C/SXT/NOR 1 (1.7%) 0 1 (2.9%) 0 0
TE/GEN/TIC/AMP/C/SXT 1 (1.7%) 0 1 (2.9%) 0 0
TE/TIC/AMP/C/SXT/NOR 5 (8.6%) 0 5 (14.7%) 0 0
CRO/TE/CFZ/TIC/AMP/C 1 (1.7%) 0 1 (2.9%) 0 0
CRO/TE/CFP/CFZ/AMP/SXT 1 (1.7%) 1 (12.5%) 0 0 0
CRO/CFP/CFZ/TIC/TE/AMP/C 2 (3.4%) 0 0 2 (16.7%) 0
CRO/TE/CFZ/TIC/AMP/C/SXT 1 (1.7%) 0 1 (2.9%) 0 0
TE/TIC/AMP/C/TO/GEN/SXT/NOR 1 (1.7%) 0 0 1 (8.3%) 0
CRO/PIP/TE/CFP/CFZ/TIC/AMP/C 1 (1.7%) 0 1 (2.9%) 0 0
CRO/PIP/TE/CFP/CFZ/TIC/AMP/SXT 1 (1.7%) 0 1 (2.9%) 0 0
CRO/PIP/TE/CFP/CFZ/TIC/AMP/C/NOR 1 (1.7%) 0 1 (2.9%) 0 0
CRO/TE/CFP/CFZ/LEV/TIC/AMP/C/NOR 1 (1.7%) 1 (12.5%) 0 0 0
CRO/PIP/TE/CFP/CFZ//TOTIC/AMP/C/NOR 1 (1.7%) 0 0 1 (8.3%) 0
CRO/PIP/TE/CFZ/TO/TIC/TIM/AMP/C/NOR 1 (1.7%) 0 1 (2.9%) 0 0
CRO/PIP/TE/CFP/CFZ/TIC/ATM/AMP/C/SXT 1 (1.7%) 1 (12.5%) 0 0 0
CRO/PIP/TE/CFP/CFZ/TIC/TIM/AMP/C/NOR 2 (3.4%) 1 (12.5%) 0 1 (8.3%) 0
CRO/TE/CFZ/FOX/TO/TIC/AMP/C/SXT/NOR 2 (3.4%) 0 2 (5.9%) 0 0
CRO/PIP/TE/CFP/CFZ/FOX/TIC/AMP/C/NOR 1 (1.7%) 0 1 (2.9%) 0 0
CRO/TE/CFZ/FOX/TO/GEN/TIC/AMP/C/SXT/NOR 2 (3.4%) 0 2 (5.9%) 0 0
CRO/PIP/TE/CFP/CFZ/TO/GEN/TIC/TIM/AMP/C 1 (1.7%) 0 1 (2.9%) 0 0
CRO/PIP/TE/CFP/CFZ/TO/GEN/TIC/TIM/AMP/C/NOR 1 (1.7%) 0 1 (2.9%) 0 0
CRO/PIP/TE/CFP/CFZ/TO/GEN/TIC/AMP/C/SXT/NOR 1 (1.7%) 0 1 (2.9%) 0 0
TABLE 4 | Resistance to quinolones or cephalosporin of 58 S. flexneri serotype 2 variant isolates from different regions of China during 2003–2008 and
2009–2013.
Resistance to
quinolones or
cephalosporin
No. (%) isolates P-value
Total (n = 58) Shanghai (n = 34) Henan (n = 12) Guangxi (n = 4) Xinjiang (n = 8)
2003–2008
(n = 39)
2009–2013
(n = 19)
2003–2008
(n = 21)
2009–2013
(n = 13)
2003–2008
(n = 9)
2009–2013
(n = 3)
2003–2008
(n = 4)
2009–2013
(n = 0)
2003–2008
(n = 5)
2009–2013
(n = 3)
Non 21 (53.8) 3 (15.8) 9 (42.9) 1 (7.7) 6 (66.7) 1 (33.3) 4 (100) 0 2 (40) 1 (33.3) ≤0.01
Cephalosporin 13 (33.3) 9 (47.4) 8 (38.1) 6 (46.2) 3 (33.3) 1 (33.3) 0 0 2 (40) 2 (66.7) 0.3
Quinolones 7 (17.9) 15 (78.9) 4 (19) 12 (92.3) 3 (33.3) 2 0 0 2 (40) 1 (33.3) ≤0.01
Both 2 (5.1) 8 (42.1) 0 7 (53.8) 3 (33.3) 1 (33.3) 0 0 1 (20) 1 (33.3) ≤0.01
to the same sequence type, which was designated ST100. ST100
also contained multiple other serotypes such as 1a, 1c, 2a, 2b, and
Y, suggesting that ST100 has been circulating among different S.
flexneri serotypes for a long time in China. PFGE was further
performed to determine genetic relatedness among the isolates
of serotype 2 variant and other serotypes. With a similarity
of 80%, all the serotype 2 variant strains except two isolates
(SH05Sh584 and SH12Sh282) formed a single cluster (containing
2a and 2b isolates). This result suggested that the serotype 2
variant strains were closely related to serotype 2a and 2b. Besides,
the 58 S. flexneri serotype 2 variant isolates generated 45 PFGE
patterns (Figure 3), suggesting a high genetic diversity among the
serotype 2 variant strains.
Molecular Analysis of Antibiotic-Resistance
Determinants and Integrons
Twenty-two of 58 isolates showing resistance to cephalosporin
were selected to test for antibiotic-resistance determinants
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FIGURE 3 | Pulsed-field gel electrophoresis dendrogram and the antibiotic resistance profile of S. flexneri serotype 2 variant, 2a, and 2b isolates. The
original number, origin, serotype, and isolation year are indicated for each strain.
and integrons, including the blaVIM, blaNDM, blaSHV, blaTEM,
blaOXA, blaCTX−M, intI1, and intI2 gene regions (Table 5). PCR
screenings showed that all strains were negative for blaSHV,
blaVIM, and blaNDM, but positive for blaTEM, blaOXA, and
blaCTX−M. Sequencing results using primers amplifying the
whole blaTEM gene showed 100% identity with the blaTEM−1
gene. All except two isolates from Shanghai and one isolate from
Xinjiang harbored blaOXA−1. Besides, 18 isolates contained the
blaCTX−M gene; nine isolates from Shanghai, two from Xinjiang,
and one from Henan harbored blaCTX−M−14; three isolates from
Shanghai and one isolate from Henan harbored blaCTX−M−3;
and one isolate from Xinjiang and one isolate from Henan
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TABLE 5 | Antibiogram and molecular analysis of the antibiotic-resistance determinants and integrons of S. flexneri serotype 2 variant isolates with
resistance to cephalosporin.
Strain No. Antibiogram Antibiotic-resistant determinants and integrons present
STRAINS RESISTANT TO CEPHALOSPORIN
2004607 CRO/TE/CFP/CFZ/AMP/SXT IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaTEM1
SH05Sh584 CRO/TE/CFZ/TIC/AMP/C/SXT IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−14
HN08166 CRO/TE/CFP/CFZ/TIC/AMP/C IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−14
HN08175 CRO/TE/CFP/CFZ/TIC/AMP/C IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1
SH05Sh582 CRO/PIP/TE/CFP/CFZ/TIC/AMP/C IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−3
SH05Sh10 CRO/PIP/TE/CFP/CFZ/TIC/AMP/C IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−14
SH05Sh9 CRO/PIP/TE/CFP/CFZ/TIC/AMP/SXT IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaTEM1, blaCTX−M−14
SH05sh375 CRO/PIP/TE/CFP/CFZ/TIC/AMP/SXT IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaTEM1, blaCTX−M−14
SH05Sh39 CRO/PIP/TE/CFP/CFZ/TIC/AMP/SXT IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−14
SH09sh2-2 CRO/PIP/TE/CFP/CFZ/TIC/AMP/C/NOR IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−14
SH12Sh104 CRO/PIP/TE/CFP/CFZ/TIC/AMP/C/NOR IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−14
2006040 CRO/TE/CFP/CFZ/LEV/TIC/AMP/C/NOR IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−14
SH05sh48 CRO/PIP/TE/CFZ/TO/TIC/TIM/AMP/C IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−3
2012262 CRO/PIP/TE/CFP/CFZ/TIC/TIM/AMP/C/NOR IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−14
HN08096 CRO/PIP/TE/CFP/CFZ/TO/TIC/AMP/C/NOR IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−3
SH13Sh70 CRO/TE/CFZ/FOX/TO/TIC/AMP/C/SXT/NOR IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1
SH12Sh111 CRO/PIP/TE/CFP/CFZ/FOX/TIC/AMP/C/NOR IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−14
2011154 CRO/PIP/TE/CFP/CFZ/TIC/ATM/AMP/C/SXT IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−79
HN12152 CRO/PIP/TE/CFP/CFZ/TIC/ATM/AMP/C/NOR IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−79
SH05sh394 CRO/PIP/TE/CFP/CFZ/TO/GEN/TIC/TIM/AMP/C IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1, blaCTX−M−3
SH13Sh32 NIT/TE/CFZ/FOX/TO/GEN/TIC/AMP/C/SXT/NOR IntI1 (blaOXA−30+aadA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1
SH12Sh160 CRO/PIP/TE/CFP/CFZ/TO/GEN/TIC/AMP/C/SXT/NOR IntI1 (blaOXA−30+aadA1; aacA4+cmlA1), IntI2 (dfrA1+sat1+aadA1), blaOXA1, blaTEM1,
blaCTX−M−14
harbored blaCTX−M−79. All isolates harbored class 1 integrons
with blaOXA−30 and aadA1 gene cassettes, and one isolate from
Shanghai harbored aacA4 and cmlA1 gene cassettes. All of the
isolates harbored class 2 integrons following dfrA1, sat1, and
aadA1 gene cassettes. In 22 quinolone-resistant isolates, no
point mutations in QRDRs of gyrB and parE were found, but
point mutations in QRDRs of gyrA and parC were identified
in each resistant isolate. All of the norfloxacin-resistant isolates
had the gyrA mutation of Ser83Leu and the parC mutations of
Ser80Ile and His211Tyr in our study. Interestingly, the strain
2006040 (the only isolate resistant to levofloxacin) from Xinjiang
and strain HN08096 from Henan had the gyrA mutation of
Asp87Asn, while the rest of the strains except strain HN09103
had the gyrA mutation of Asp87Gly. Only two species of PMQR
determinants [qnrS and aac(6′)-Ib-cr] were identified. All of the
isolates harbored the aac(6′)-Ib-cr gene, and only two isolates
from Shanghai harbored qnrS. Sequencing analysis determined
that the two qnrS genes were qnrS1 (Table 6).
Discussion
The emergence of MDR strains has become a serious problem
and has complicated the selection of empirical treatment for
shigellosis. In the present study, the serotype 2 variant isolates
were highly resistant to ampicillin, chloramphenicol, tetracycline,
and ticarcillin, and 98.3% of these isolates showed MDR profiles.
One of the reasons for the rapid accumulation of resistance is
excessive or inappropriate use of antibiotics in outpatients in
China (Pickering, 2004; Zhang et al., 2011).
Our study further indicates that current resistance patterns
have changed and that empirical therapy should keep pace with
these changes. According to previous results, fluoroquinolones
and third-generation cephalosporins are probably the best choice
for empiric treatment of severe gastrointestinal infections caused
by pathogenic bacteria (Gendrel et al., 2008). However, the
resistance rates of these isolates to fluoroquinolones and third-
generation cephalosporins in the serotype 2 variant strains have
increased at an alarming rate, and continuous surveillance of
the resistance pattern will be essential to choose the appropriate
antimicrobial therapy.
The increasing antibiotic resistance rate led us to study the
genetics and mechanisms of antibiotic resistance. The horizontal
transfer of integrons may account for the dissemination of
resistance genes, and resistance to some antibiotics is associated
with the presence of class 1 and class 2 integrons containing
resistance gene cassettes (Ke et al., 2011). In the current study,
blaOXA−30 and aadA1 were detected in the gene cassettes of class
1 integrons, and dfrA1+sat1+aadA1 was detected in the gene
cassettes of class 2 integrons. In addition, of the 22 cephalosporin-
resistant isolates, 100% harbored the blaTEM−1 resistance gene,
81.8% harbored the blaCTX resistance gene, and 90.9% harbored
the blaOXA resistance gene. Additionally, the strong ability to
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TABLE 6 | Antibiogram and molecular analysis of the antibiotic-resistance determinants and integrons of S. flexneri serotype 2 variant isolates with
resistance to fluoroquinolone.
Strain No. Antibiogram PMQR determinant Amino acid in QRDR
parC gyrA
aac(6′)-Ib-cr qnrS 80Ser 83Ser 87Asp 211His
STRAINS RESISTANT TO FLUOROQUINOLONE
SH07Sh007 TIC/AMP/C/NOR + – Ile Leu Gly Tyr
SH08Sh265 TIC/AMP/C/NOR + – Ile Leu Gly Tyr
2006095 TE/TIC/AMP/C/NOR + – Ile Leu Gly Tyr
SH12Sh282 TE/TIC/AMP/C/NOR + – Ile Leu Gly Tyr
SH09sh188-2 TE/TIC/AMP/C/NOR + – Ile Leu Gly Tyr
SH12Sh219 TIC/AMP/C/SXT/NOR + – Ile Leu Gly Tyr
SH05sh577 TE/TIC/AMP/C/SXT/NOR + + Ile Leu Gly Tyr
SH11sh473 TE/TIC/AMP/C/SXT/NOR + – Ile Leu Gly Tyr
SH12Sh119 TE/TIC/AMP/C/SXT/NOR + – Ile Leu Gly Tyr
SH13Sh40 TE/TIC/AMP/C/SXT/NOR + – Ile Leu Gly Tyr
SH05sh585 TE/TIC/AMP/C/SXT/NOR + – Ile Leu Gly Tyr
HN09103 TE/TO/GEN/TIC/AMP/C/SXT/NOR + – Ile Leu Asp Tyr
SH09sh2-2 CRO/PIP/TE/CFP/CFZ/TIC/AMP/C/NOR + – Ile Leu Gly Tyr
SH12Sh104 CRO/PIP/TE/CFP/CFZ/TIC/AMP/C/NOR + – Ile Leu Gly Tyr
2006040 CRO/TE/CFP/CFZ/LEV/TIC/AMP/C/NOR + – Ile Leu Asn Tyr
SH13Sh70 CRO/TE/CFZ/FOX/TO/TIC/AMP/C/SXT/NOR + – Ile Leu Gly Tyr
HN08096 CRO/PIP/TE/CFP/CFZ/TO/TIC/AMP/C/NOR + – Ile Leu Asn Tyr
HN12152 CRO/PIP/TE/CFP/CFZ/TIC/ATM/AMP/C/NOR + – Ile Leu Gly Tyr
2012262 CRO/PIP/TE/CFP/CFZ/TIC/TIM/AMP/C/NOR + – Ile Leu Gly Tyr
SH12Sh111 CRO/PIP/TE/CFP/CFZ/FOX/TIC/AMP/C/NOR + + Ile Leu Gly Tyr
SH13Sh32 NIT/TE/CFZ/FOX/TO/GEN/TIC/AMP/C/SXT/NOR + – Ile Leu Gly Tyr
SH12Sh160 CRO/PIP/TE/CFP/CFZ/TO/GEN/TIC/AMP/C/SXT/NOR + – Ile Leu Gly Tyr
acquire resistance genes facilitated the survival of bacteria under
the pressure of various antibiotics. The blaTEM−1 gene was
detected in all of the ESBL-producing isolates; this gene exists
at high frequencies in antibiotic-resistant bacteria across the
globe and confers resistance to penicillin and other β-lactamase
antibiotics (Barlow and Hall, 2003). OXA-type β-lactamases
confer resistance to ampicillin and cephalothin, and they are
characterized by high hydrolytic activity against oxacillin and
cloxacillin (Bradford, 2001). Sequencing analysis showed that all
of the blaOXA genes were blaOXA−1, indicating the host specificity
for this subtype in S. flexneri, which is consistent with the result
of a previous study (Siu et al., 2000).
Fluoroquinolone resistance in Enterobacteriaceae has been
mostly attributed to modifications in the QRDRs of the gyrA
and parC genes and/or PMQR determinants such as qnr and
[aac(6′)-Ib-cr] (Folster et al., 2011). In the current study,
95% of the quinolone-resistant Shigella isolates had at least
three point mutations in gyrA (Ser83Leu, Asp87Gly/Asn, and
His211Tyr) and parC (Ser80Ile). Furthermore, different amino
acid substitutions at the same position may result in different
quinolone susceptibility levels (Ruiz, 2003). The His211Tyr
mutation in gyrA was detected in resistant S. flexneri serotype
2a strains from Bangladesh (Azmi et al., 2014). Notably, all
of the quinolone-resistant isolates in our study had the gyrA
mutation of His211Tyr. PMQR determinants are located on
mobile genetic elements (i.e., plasmids), which may allow for
dissemination among Shigella (Folster et al., 2011). The presence
of the qnr gene can facilitate the selection of chromosomal
mutations that cause quinolone resistance (Jacoby et al., 2003;
Martinez-Martinez et al., 2003). Worldwide, S. flexneri serotypes
1a, 2a, 2b, and 4c carrying the qnrS gene were reported with
low incidence (Hata et al., 2005; Pu et al., 2009). In our study,
only two strains from Shanghai carried the qnrS1 gene with a
percentage of 3.4%, and one of the qnrS-positive strains was the
only isolate that was resistant to levofloxacin. The aac(6′)-Ib-cr
gene is identified in many Enterobacteriaceae and is responsible
for low-level resistance to fluoroquinolones (Frasson et al., 2011).
The aac(6′)-Ib-cr–positive S. flexneri 2a strain was first isolated in
1998 (Pu et al., 2009), and all of the 17 quinolone-resistant isolates
were aac(6′)-Ib-cr–positive, suggesting that the aac(6′)-Ib-cr gene
had been present in China for many years.
Serotype conversion is a major mechanism for S. flexneri
to escape protective host immune responses, which may drive
the emergence of novel and atypical serotypes under pressure
(Allison and Verma, 2000). Based on phenotypic and genotypic
analysis, the serotype 2 variant is likely to originate from
serotypes 2a and 2b, which have experienced changes in their
genome to adapt to altered environmental conditions. The
serotype 2 variant was circulated as a major serotype during our
11-year study period, and the widespread dissemination of this
serotype poses a serious threat to public health not only in China
but also in the world.
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In summary, studies on the serotype 2 variant have become
very important owing to the increased epidemic frequency and
the prevalence of MDR strains. In view of the fact that this
serotype was prevalent in several provinces in China, it is likely
to provoke a major crisis because MDR clones can and may
have already spread to other countries. Therefore, continuous
surveillance will be needed to determine the distribution and
resistance development of this serotype so as to understand
the actual disease burden and provide guidance for the clinical
treatment of shigellosis.
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